These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887 [TBL] [Abstract][Full Text] [Related]
23. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438 [TBL] [Abstract][Full Text] [Related]
24. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365 [TBL] [Abstract][Full Text] [Related]
25. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925 [TBL] [Abstract][Full Text] [Related]
26. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma. Ak I; Gulbas Z Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019 [TBL] [Abstract][Full Text] [Related]
27. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies. Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301 [TBL] [Abstract][Full Text] [Related]
28. The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance. Nam HY; Kim SJ; Kim IJ; Kim BS; Pak K; Kim K Clin Nucl Med; 2010 Oct; 35(10):759-63. PubMed ID: 20838282 [TBL] [Abstract][Full Text] [Related]
29. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma. Hanaoka K; Hosono M; Usami K; Tatsumi Y; Yamazoe Y; Komeya Y; Tsuchiya N; Ishii K; Sumita M Nucl Med Commun; 2011 Aug; 32(8):678-83. PubMed ID: 21499162 [TBL] [Abstract][Full Text] [Related]
30. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Kazama T; Swanston N; Podoloff DA; Macapinlac HA Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1406-11. PubMed ID: 16133379 [TBL] [Abstract][Full Text] [Related]
31. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma. Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594 [TBL] [Abstract][Full Text] [Related]
32. Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection. Lee JW; Lee MS; Chung IK; Son MW; Cho YS; Lee SM World J Gastroenterol; 2017 Apr; 23(13):2385-2395. PubMed ID: 28428718 [TBL] [Abstract][Full Text] [Related]
33. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658 [TBL] [Abstract][Full Text] [Related]
35. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Kim J; Yoo SW; Kang SR; Bom HS; Song HC; Min JJ Ann Hematol; 2014 Apr; 93(4):661-7. PubMed ID: 24061788 [TBL] [Abstract][Full Text] [Related]
36. (18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors. Morooka M; Kubota K; Murata Y; Shibuya H; Ito K; Mochizuki M; Akashi T; Chiba T; Nomura T; Ito H; Morita T Ann Nucl Med; 2008 Aug; 22(7):635-9. PubMed ID: 18756367 [TBL] [Abstract][Full Text] [Related]
37. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes. Inoue K; Okada K; Harigae H; Taki Y; Goto R; Kinomura S; Kato S; Kaneta T; Fukuda H Clin Nucl Med; 2006 Nov; 31(11):721-3. PubMed ID: 17053396 [TBL] [Abstract][Full Text] [Related]
38. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation? Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567 [TBL] [Abstract][Full Text] [Related]
39. Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET. Nakamoto Y; Suga T; Hara T; Ishizu K; Togashi K Clin Nucl Med; 2010 Feb; 35(2):74-6. PubMed ID: 20090448 [TBL] [Abstract][Full Text] [Related]
40. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Rose BS; Liang Y; Lau SK; Jensen LG; Yashar CM; Hoh CK; Mell LK Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1185-91. PubMed ID: 22270171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]